» Articles » PMID: 35979158

Utility of a Deep Learning Model and a Clinical Model for Predicting Bleeding After Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer

Overview
Specialty Gastroenterology
Date 2022 Aug 18
PMID 35979158
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bleeding is one of the major complications after endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) patients. There are limited studies on estimating the bleeding risk after ESD using an artificial intelligence system.

Aim: To derivate and verify the performance of the deep learning model and the clinical model for predicting bleeding risk after ESD in EGC patients.

Methods: Patients with EGC who underwent ESD between January 2010 and June 2020 at the Samsung Medical Center were enrolled, and post-ESD bleeding (PEB) was investigated retrospectively. We split the entire cohort into a development set (80%) and a validation set (20%). The deep learning and clinical model were built on the development set and tested in the validation set. The performance of the deep learning model and the clinical model were compared using the area under the curve and the stratification of bleeding risk after ESD.

Results: A total of 5629 patients were included, and PEB occurred in 325 patients. The area under the curve for predicting PEB was 0.71 (95% confidence interval: 0.63-0.78) in the deep learning model and 0.70 (95% confidence interval: 0.62-0.77) in the clinical model, without significant difference ( = 0.730). The patients expected to the low- (< 5%), intermediate- (≥ 5%, < 9%), and high-risk (≥ 9%) categories were observed with actual bleeding rate of 2.2%, 3.9%, and 11.6%, respectively, in the deep learning model; 4.0%, 8.8%, and 18.2%, respectively, in the clinical model.

Conclusion: A deep learning model can predict and stratify the bleeding risk after ESD in patients with EGC.

Citing Articles

Characteristics of early gastric tumors with different differentiation and predictors of long-term outcomes after endoscopic submucosal dissection.

Zhu H, Wu J, Zhang Y, Li F, Yang J, Qin B World J Gastroenterol. 2024; 30(14):1990-2005.

PMID: 38681129 PMC: 11045489. DOI: 10.3748/wjg.v30.i14.1990.


Early gastric cancer recurrence after endoscopic submucosal dissection: Not to be ignored!.

Zeng Y, Yang J, Zhang J World J Gastrointest Oncol. 2024; 16(1):8-12.

PMID: 38292847 PMC: 10824107. DOI: 10.4251/wjgo.v16.i1.8.

References
1.
Lim J, Kim S, Kim J, Choi Y, Kwon J, Kim J . Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms?. Gastrointest Endosc. 2012; 75(4):719-27. DOI: 10.1016/j.gie.2011.11.034. View

2.
Lim H, Gong E, Min B, Kang S, Shin C, Byeon J . Clinical Practice Guideline for the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy. Clin Endosc. 2020; 53(6):663-677. PMC: 7719428. DOI: 10.5946/ce.2020.192. View

3.
Sanomura Y, Oka S, Tanaka S, Numata N, Higashiyama M, Kanao H . Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastric Cancer. 2013; 17(3):489-96. PMC: 4072060. DOI: 10.1007/s10120-013-0305-3. View

4.
Numata N, Oka S, Tanaka S, Higashiyama M, Sanomura Y, Yoshida S . Clinical outcomes of endoscopic submucosal dissection for early gastric cancer in patients with chronic kidney disease. J Gastroenterol Hepatol. 2013; 28(10):1632-7. DOI: 10.1111/jgh.12320. View

5.
Hashimoto M, Hatta W, Tsuji Y, Yoshio T, Yabuuchi Y, Hoteya S . Rebleeding in patients with delayed bleeding after endoscopic submucosal dissection for early gastric cancer. Dig Endosc. 2021; 33(7):1120-1130. DOI: 10.1111/den.13943. View